Gastric cancer (aka stomach cancer) develops when cells in the stomach grow and divide abnormally1. While occurrence of gastric cancer has declined over the past 2 decades, it remains the 5th most prevalent cancer worldwide2. The most common type of gastric cancer is adenocarcinoma, which begins in the inner lining of the stomach1.
Risk factors for gastric cancer may include H. pylori infections, other medical conditions (such as gastritis, obesity, and gastroesophageal reflux disease [GERD]), genetics and family history, diet, tobacco use, and environmental/occupational exposures2.
Stomach cancer is most often advanced at diagnosis. Advanced stages mean the cancer can be treated but is rarely cured. Five-year survival rates differ based on location of the cancer. For localized gastric cancer (meaning it is still within the stomach) the survival rate is 75%; for regional and metastatic cancer it is 35% and 7% respectively3.
The Association of Cancer Care Centers (ACCC) has developed an initiative titled, Optimizing Outcomes in Advanced/Metastatic Gastric Cancer to support health care providers in applying evidence-based treatment selection for patients with advanced/metastatic gastric cancer.
For more information on this project, please contact the ACCC Provider Education department.
Developed under the direction and sponsorship of Lilly Medical Affairs and is intended for US healthcare professionals only. VV-OTHR-US-DEL-2428, 11/2023. ©2023 Lilly USA, LLC. All rights reserved.
